HER2 expression in patients (pts) with surgically resected urothelial cancer at high risk of recurrence screened for the phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2 Meeting Abstract
| Authors: | Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Gomella, L. G.; Quinn, D. I.; Sharma, P.; DeVries, T.; Sims, R. B.; Chen, M.; Bajorin, D. F. |
| Abstract Title: | HER2 expression in patients (pts) with surgically resected urothelial cancer at high risk of recurrence screened for the phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2 |
| Meeting Title: | 2013 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2013 Feb 14-16 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-20 |
| Language: | English |
| ACCESSION: | WOS:000333679600292 |
| DOI: | 10.1200/jco.2013.31.6_suppl.292 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 292 -- Source: Wos |
